G/MA/QR/N/AUS/5/Add.5  
 
23 February  2023 
(23-1303) Page: 1/2 
Committee on Market Access  Original: English  
 
  
NOTIFICATION PURSUANT TO THE DECISION ON NOTIFICATION  PROCEDURE S 
FOR QUANTITATIVE RESTRICTIONS (G/L/59/REV.1)  
AUSTRALIA  
Addendum  
The following communication, dated 22 February  2023, is being circulated at the request of the 
delegation of Australia . 
 
A. Notifying Member : Australia  
B. Date of notification : 22 February  2023 
C. First time notification:  
 Yes 
 No, last notification was made in (doc. symbol ): G/MA/QR/N/AUS/5/Add.3  
D. Type of notification:  
 1. Complete (i.e.  notification of all quantitative restrictions in force ) 
 2. Changes to a notification previously made in G/MA/QR/N/AUS/5/Add.3  which  are of 
the follow ing nature : 
 2.1 Introduction of new restrictions, as listed in Section 1. 
 2.2 Elimination of restrictions, as described in G below . 
 2.3 Modification of a previously notified restriction, as described in Section 1. 
 3. Reverse notification of restrictions maintained by (Member ):  
E. The notification provides information for the follo wing biennial period 
(e.g.  2012 -2014): 2020-2022 and relates to restrictions in force as of 17 April 2022 
F. This notification contains information* relating to:  
 Section  1: List of quantitative restrictions that are currently in force . 
 Section  2: Cross -reference to other WTO notifications with information on quantitative 
restrictions that are currently in force and additional information . 
G. Comments of a general nature, including a description of the elimination of 
restrictions notified under D.2.2 and the date they ceased to be in force.  
This notification communicates the elimination of the previously notified measure on 
COVID -19 rapid antigen test kits. The measure ceased on 17 April 2022.  
 
* In English  only.  
  G/MA/QR/N/AUS/5/Add.5  
 
- 2 - Section  1: List of quantitative restrictions that are currently in force  
 
QR 
No. General 
description 
of the 
restriction  Type of 
restriction  Tariff line 
code(s) 
affected, 
based on 
HS(201 7) Detailed Product 
Description  WTO Justification  and 
Grounds for Restriction, 
e.g., Other 
International 
Commitments  National legal basis and entry 
into force  Administration, modification 
of previously notified  
measures, and other 
comments  
1 2 3 4 5 6 7 
1 Restriction on 
exports of 
COVID -19 
rapid antigen 
test kits  CP-X 3822.19.09  COVID -19 rapid 
antigen test kit  Article XI.2(a) of the 
GATT  Biosecurity (Human Biosecurity 
Emergency) (Human Coronavirus 
with Pandemic Pot ential) (COVID -
19 Rapid Antigen Tests) 
Determination 2022 . 
 
The Determination is made under 
subsection 477(1) of the 
Biosecurity Act 2015 (Cth). 
 
The measure was in place from 8 
January 2022. The measure 
ceased on 17 April 2022.  The Determination prohibited the 
exports of COVID -19 rapid 
antigen test kits unless an 
exception under section 9 of the 
Determination applied. Section 9 
outlined exceptions for both non -
commercial and commercial 
purposes.  
 
This was a temporary measure to 
ensure that COVID -19 rapid 
antigen test kits were reasonably 
and appropriately available to 
individuals who required a test, as 
part of Australia’s public health 
response to controlling the spread 
of COVID -19. 
__________